Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam 7.5mg in Knee Osteoarthritis
NCT02183116Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1998
- Primary completion
- Feb 1999
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of meloxicam in osteoarthritis (OA), sponsored by Boehringer Ingelheim. Started Oct 1998; status: completed.
02
Drugs
meloxicam
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02183116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02183116.